EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Glycemic Control and Cardiovascular Risk in Type 2 Diabetics Using Metformin vs. Combination Therapy

Sehrish Jabeen, Anam, Fatima Abass, Syeda Aisha, Saba Khalid

Innovative Research in Applied, Biological and Chemical Sciences · 2025

DOI: 10.62497/irabcs.141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Innovative Research in Applied, Biological and Chemical Sciences, 2025. Verfasst von Sehrish Jabeen und 4 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Type 2 diabetes mellitus (T2DM) is a growing public health concern worldwide. While metformin is the first-line therapy, many patients require additional oral antidiabetic drugs (OADs) to achieve glycemic targets.

Objective

To determine which is better at controlling blood sugar and lowering the risk of heart disease in people with type 2 diabetes: metformin monotherapy or combination treatment. Materials and Methods: The descriptive, cross-sectional research was conducted at the Department of Endocrinology at Jinnah Hospital in Lahore between February 2023 and January 2024. A total of 132 T2DM patients were enrolled using convenience sampling and divided into two groups: Group A (metformin only; n=62) and Group B (metformin plus OADs; n=70). Fasting blood glucose, HbA1c, blood pressure, and lipid profile were assessed. Independent samples t-tests were used to compare means between groups, with p

Zitieren

APA

Jabeen, S., Anam, Abass, F., Aisha, S., & Khalid, S. (2025). Glycemic Control and Cardiovascular Risk in Type 2 Diabetics Using Metformin vs. Combination Therapy. Innovative Research in Applied, Biological and Chemical Sciences. https://doi.org/10.62497/irabcs.141

Vancouver

Jabeen S, Anam, Abass F, Aisha S, Khalid S. Glycemic Control and Cardiovascular Risk in Type 2 Diabetics Using Metformin vs. Combination Therapy. Innovative Research in Applied, Biological and Chemical Sciences. 2025. doi:10.62497/irabcs.141

BibTeX
@article{Jabeen2025,
  author = {Jabeen, Sehrish and Anam and Abass, Fatima and Aisha, Syeda and Khalid, Saba},
  title = {Glycemic Control and Cardiovascular Risk in Type 2 Diabetics Using Metformin vs. Combination Therapy},
  journal = {Innovative Research in Applied, Biological and Chemical Sciences},
  year = {2025},
  doi = {10.62497/irabcs.141}
}
Kostenlos starten →